• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于公共卫生的迷幻剂管理与监管愿景。

A Public-Health-Based Vision for the Management and Regulation of Psychedelics.

作者信息

Haden Mark, Emerson Brian, Tupper Kenneth W

机构信息

a Adjunct Professor, School of Population and Public Health , University of British Columbia , Vancouver , Canada.

b Chair of the Board of MAPS (Multidisciplinary Association for Psychedelic Studies) Canada, School of Population and Public Health , Vancouver , Canada.

出版信息

J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.

DOI:10.1080/02791072.2016.1202459
PMID:27430375
Abstract

The Health Officers Council of British Columbia has proposed post-prohibition regulatory models for currently illegal drugs based on public health principles, and this article continues this work by proposing a model for the regulation and management of psychedelics. This article outlines recent research on psychedelic substances and the key determinants of benefit and harm from their use. It then describes a public-health-based model for the regulation of psychedelics, which includes governance, supervision, set and setting controls, youth access, supply control, demand limitation, and evaluation.

摘要

不列颠哥伦比亚省卫生官员理事会基于公共卫生原则,针对目前的非法药物提出了禁令后监管模式,本文通过提出一种迷幻剂监管与管理模式延续了这项工作。本文概述了关于迷幻物质的最新研究以及使用这些物质的利弊关键决定因素。然后描述了一种基于公共卫生的迷幻剂监管模式,其中包括治理、监督、环境与背景控制、青年接触限制、供应控制、需求限制和评估。

相似文献

1
A Public-Health-Based Vision for the Management and Regulation of Psychedelics.基于公共卫生的迷幻剂管理与监管愿景。
J Psychoactive Drugs. 2016 Sep-Oct;48(4):243-52. doi: 10.1080/02791072.2016.1202459. Epub 2016 Jul 18.
2
New psychoactive substances: a public health issue.新型精神活性物质:一个公共卫生问题。
Int J Pharm Pract. 2017 Oct;25(5):323-325. doi: 10.1111/ijpp.12313.
3
Crisis intervention related to the use of psychoactive substances in recreational settings--evaluating the Kosmicare Project at Boom Festival.与娱乐场景中使用精神活性物质相关的危机干预——对博姆音乐节上的Kosmicare项目进行评估
Curr Drug Abuse Rev. 2014;7(2):81-100. doi: 10.2174/1874473708666150107115515.
4
New psychoactive substances: Are there any good options for regulating new psychoactive substances?新型精神活性物质:对于管控新型精神活性物质,是否存在任何可行的办法?
Int J Drug Policy. 2017 Feb;40:117-122. doi: 10.1016/j.drugpo.2016.10.020. Epub 2016 Nov 23.
5
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans.评估迷幻药物的滥用潜力,作为人类医疗用途的安全药理学评估的一部分。
Neuropharmacology. 2018 Nov;142:89-115. doi: 10.1016/j.neuropharm.2018.01.049. Epub 2018 Feb 8.
6
Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.药店售卖可卡因和海洛因:减少危害的毒品合法化:刑事定罪社会的一种替代方案
Cornell J Law Public Policy. 2006 Summer;15(3):619-64.
7
Psychedelics not linked to mental health problems or suicidal behavior: a population study.迷幻剂与心理健康问题或自杀行为无关:一项人群研究。
J Psychopharmacol. 2015 Mar;29(3):270-9. doi: 10.1177/0269881114568039. Epub 2015 Mar 5.
8
Psychedelics: Where we are now, why we got here, what we must do.迷幻剂:我们现在在哪里,我们为什么会在这里,我们必须做什么。
Neuropharmacology. 2018 Nov;142:7-19. doi: 10.1016/j.neuropharm.2018.02.018. Epub 2018 Feb 21.
9
Assessing the 'added value' of European policy on new psychoactive substances.评估欧洲新精神活性物质政策的“附加值”。
Int J Drug Policy. 2017 Feb;40:111-116. doi: 10.1016/j.drugpo.2016.11.002. Epub 2016 Dec 10.
10
Public health, not social warfare: a public health approach to illegal drug policy.公共卫生,而非社会战争:非法毒品政策的公共卫生方法
J Public Health Policy. 1991 Autumn;12(3):278-323.

引用本文的文献

1
Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options.《超越<管制物质法>的迷幻药监管:描述政策选项的三维框架》
Am J Psychiatry. 2025 Jan 1;182(1):6-9. doi: 10.1176/appi.ajp.20230787.
2
Set and setting in microdosing: an oft-overlooked principle.微剂量服用中的环境与背景:一个常被忽视的原则。
Psychopharmacology (Berl). 2022 Dec;239(12):3771-3777. doi: 10.1007/s00213-022-06249-8. Epub 2022 Oct 27.
3
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD).
使用麦角酸二乙基酰胺(LSD)后寻求紧急医疗救治的不良体验。
J Psychopharmacol. 2022 Aug;36(8):956-964. doi: 10.1177/02698811221099650. Epub 2022 Jun 7.
4
Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.将迷幻疗法从临床试验推广至社区诊所:架起桥梁并应对未来潜在挑战
Front Psychiatry. 2021 Nov 4;12:737738. doi: 10.3389/fpsyt.2021.737738. eCollection 2021.
5
Reprint of: The regulation project: Tools for engaging the public in the legal regulation of drugs.重印:《监管项目:让公众参与药品法律监管的工具》
Int J Drug Policy. 2021 May;91:103279. doi: 10.1016/j.drugpo.2021.103279.
6
The regulation project: Tools for engaging the public in the legal regulation of drugs.监管项目:让公众参与药品法律监管的工具。
Int J Drug Policy. 2020 Oct 10;86:102949. doi: 10.1016/j.drugpo.2020.102949.